(Firm/Analyst in alphabetical order)
| Barclays Capital Japan Limited | Atsushi Seki |
|---|---|
| Citigroup Global Markets Japan Inc. | Hidemaru Yamaguchi |
| Cosmo Securities Co., Ltd. | Kazuyoshi Saito |
| Credit Suisse Securities (Japan) Limited | Fumiyoshi Sakai |
| Daiwa Securities Capital Markets Co. Ltd. | Akitada Iwasa |
| Deutsche Securities Inc. | Kenji Masuzoe |
| Goldman Sachs Japan Co., Ltd. | Steve Chesney |
| JPMorgan Securities Japan Co., Ltd. | Masayuki Onozuka |
| Merrill Lynch Japan Securities Co., Ltd. | Ritsuo Watanabe |
| Mito Securities Co., Ltd. | Jun Ikeyama |
| Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Toshiyuki Hibino |
| Mizuho Investors Securities Co., Ltd. | Hiroki Tada |
| Mizuho Securities Co., Ltd. | Hiroshi Tanaka |
| Morgan Stanley MUFG Securities Co., Ltd. | Mayo Mita, Shinichiro Muraoka |
| Nomura Securities Co., Ltd. | Ryoichi Urushihara |
| SMBC Nikko Securities Inc. | Yasuhiro Nakazawa |
As of Dec.1, 2011
- Notes
-
Chugai Pharmaceutical is followed by the analysts listed above. Please note that any opinions, estimates or forecasts expressed by the above regarding Chugai's performance are each analyst's alone and do not represent the opinions, estimates or forecasts of Chugai or its management.
The list is made available for the convenience of investors and includes those analysts currently known by Chugai to follow the company. However, the list may not be complete and may change as firms add or delete coverage. Chugai undertakes no obligation to update this list. Nor does Chugai purport to endorse the conclusions of the above listed analysts.
Before arriving at an investment decision, investors should exercise their own personal judgment in considering a wide range of information sources. Investors are reminded that they alone ultimately bear full responsibility for their investment decisions.
